NASDAQ:ABIO

ARCA biopharma - ABIO Stock Forecast, Price & News

$2.10

+0.03 (+1.45%)

(As of 12/2/2022 12:00 AM ET)

Add

Compare

Today's Range: $2.03
▼
$2.13
50-Day Range: $1.86
▼
$2.18
52-Week Range: $1.71
▼
$2.59

Volume: 10,136 shs
Average Volume: 19,508 shs
Market Capitalization: $30.33 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Stock News Headlines

November 26, 2022 | americanbankingnews.com

ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com

November 14, 2022 | finance.yahoo.com

One ARCA biopharma, Inc. (NASDAQ:ABIO) insider upped their stake by 5,155% in the previous year

October 29, 2022 | finanznachrichten.de

ARCA biopharma, Inc.: ARCA biopharma Announces Third Quarter 2022 Financial Results

October 28, 2022 | finance.yahoo.com

ARCA biopharma Announces Third Quarter 2022 Financial Results

October 13, 2022 | msn.com

Mother, daughter set to compete in ARCA West race in Las Vegas

October 9, 2022 | foxnews.com

ARCA race ends with tempers flaring between Sammy Smith, Jesse Love

October 7, 2022 | msn.com

How to Watch NASCAR, Formula 1, ARCA and Everything Else in Racing This Weekend, October 8-9

September 20, 2022 | seekingalpha.com

ABIO ARCA biopharma, Inc.

September 15, 2022 | foxnews.com

ARCA driver Toni Breidinger becomes Victoria's Secret model: 'Little me is crying'

September 14, 2022 | msn.com

NASCAR returns to Milwaukee Mile with Craftsman Truck and ARCA series

September 11, 2022 | msn.com

Corey Heim bows out of ARCA series with Kansas Speedway win

September 4, 2022 | msn.com

Du Quoin State Fair ARCA Menards Series event postponed due to wet conditions

August 26, 2022 | tmcnet.com

SESAMI WELCOMES GLOBAL LEADER ARCA AS IT STRENGTHENS ITS GLOBAL LEADERSHIP IN CASH AUTOMATION SOLUTIONS

August 18, 2022 | msn.com

How to watch Watkins Glen ARCA Menards race: Time, TV channel, free live stream

August 2, 2022 | finance.yahoo.com

ARCA biopharma Announces Second Quarter 2022 Financial Results

July 22, 2022 | msn.com

Pocono Raceway cancels Friday ARCA events due to severe weather

July 18, 2022 | finance.yahoo.com

Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Deliver On Growth Plans?

July 5, 2022 | benzinga.com

ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website

June 21, 2022 | benzinga.com

Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

May 5, 2022 | finance.yahoo.com

ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review

May 4, 2022 | seekingalpha.com

ARCA biopharma GAAP EPS of -$0.23

May 3, 2022 | seekingalpha.com

ARCA biopharma: Activist's Pressure Could Make This Into A Liquidation Play

May 2, 2022 | finance.yahoo.com

ARCA biopharma Announces First Quarter 2022 Financial Results

April 27, 2022 | msn.com

ARCA driver charged with felony battery after allegedly punching classmate in groin

April 18, 2022 | seekingalpha.com

ARCA biopharma establishes special board committee to evaluate strategic options

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings: 8/04/2021
Today: 12/03/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 3/13/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ABIO
CUSIP: N/A
CIK: 907654
Web: arcabio.com
Phone: (720) 940-2200
Fax: 720-208-9261
Employees: 17
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,320,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -30.92%
Return on Assets: -29.00%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 23.00
Quick Ratio: 23.00

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.97 per share
Price / Book: 0.71

Miscellaneous

Outstanding Shares: 14,410,000
Free Float: 11,485,000
Market Cap: $30.33 million
Optionable: Not Optionable
Beta: 1.79

Key Executives

Dr. Michael R. Bristow M.D. (Age 77)
Ph.D., Co-Founder, Pres, CEO & Director
Comp: $363.56k

Mr. Thomas A. Keuer (Age 63)
Chief Operating Officer
Comp: $360.58k

Mr. Christopher D. Ozeroff (Age 63)
Sr. VP, Gen. Counsel & Sec.
Comp: $318.86k

Mr. C. Jeffrey Dekker CPA (Age 57)
Chief Financial Officer

Dr. Debra Marshall FACC
M.D., Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2022?: ARCA biopharma's stock was trading at $2.15 on January 1st, 2022. Since then, ABIO stock has decreased by 2.1% and is now trading at $2.1050.
View the best growth stocks for 2022 here.
When is ARCA biopharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 13th 2023.
View our ABIO earnings forecast.
How were ARCA biopharma's earnings last quarter?: ARCA biopharma, Inc. (NASDAQ:ABIO) posted its earnings results on Wednesday, August, 4th. The biopharmaceutical company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($2.37) by $2.03.
What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?: 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).
What is ARCA biopharma's stock symbol?: ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."
Who are ARCA biopharma's major shareholders?: ARCA biopharma's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Group One Trading L.P. (0.00%), SG3 Management LLC (0.00%), Citadel Advisors LLC (0.00%) and Virtu Financial LLC (0.10%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway.
View institutional ownership trends.
How do I buy shares of ARCA biopharma?: Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ARCA biopharma's stock price today?: One share of ABIO stock can currently be purchased for approximately $2.11.
How much money does ARCA biopharma make?: ARCA biopharma (NASDAQ:ABIO) has a market capitalization of $30.33 million. The biopharmaceutical company earns $-19,320,000.00 in net income (profit) each year or ($1.01) on an earnings per share basis.
How can I contact ARCA biopharma?: ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2200, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 12/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial